Long‐standing remission after 25‐OH D3 treatment in a case of chronic myelomonocytic leukaemia

Leonardo Mellibovsky, Adolfo Díez, Jaume Aubia, Xavier Nogues, Encarna Pérez‐Vila, Sergi Serrano, Robert R. Recker

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Abstract

Summary This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25‐OH vitamin D3. No side‐effects were observed. Although vitamin D3 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of longstanding remission in a patient with CMML. This ‘differentiation therapy’ might be considered as a possible alternative in the management of this disease. Copyright © 1993, Wiley Blackwell. All rights reserved
Original languageEnglish
Pages (from-to)811-812
JournalBritish Journal of Haematology
Volume85
Issue number4
DOIs
Publication statusPublished - 1 Jan 1993

Fingerprint

Dive into the research topics of 'Long‐standing remission after 25‐OH D3 treatment in a case of chronic myelomonocytic leukaemia'. Together they form a unique fingerprint.

Cite this